Vaginal atrophy and sexual dysfunction in current users of systemic postmenopausal hormone therapy

Journal of the Medical Association of Thailand

Volumn 93, Issue 6, 2010, Pages 667-675

  Indhavivadhana, Suchada ^a   Leerasiri, Pichai ^a   Rattanachaiyanont, Manee ^a   Laiwejpithaya, Somsak ^a   Tanmahasamut, Prasong ^a   Techatraisak, Kitirat ^a   Angsuwathana, Surasak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Current users; Postmenopausal hormone therapy; Sexual dysfunction; Vaginal atrophy

Indexed keywords

ESTROGEN; GESTAGEN; RALOXIFENE; TIBOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPAREUNIA; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL THERAPY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MATURATION; PELVIS; PH; PREVALENCE; VAGINA; VAGINA ATROPHY;

ADMINISTRATION, INTRAVAGINAL; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATROPHY; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME; VAGINA; VAGINAL DISEASES;

EID: 77954522752     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barlow DH, Cardozo LD, Francis RM, Griffin M, Hart DM, Stephens E, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997; 104: 87-91.
2. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/ Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 1999; 94: 66-70.
3. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63: 257-60.
4. Jackson S, Shepherd A, Brookes S, Abrams P. The effect of oestrogen supplementation on post- menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol 1999; 106: 711-8.
5. Samuelsson E, Victor A, Svardsudd K. Determinants of urinary incontinence in a population of young and middle-aged women. Acta Obstet Gynecol Scand 2000; 79: 208-15.
6. Tungphaisal S, Chandeying V, Sutthijumroon S, Krisanapan O, Udomratn P. Postmenopausal sexuality in Thai women. Asia Oceania J Obstet Gynaecol 1991; 17: 143-6.
7. Heimer G, Samsioe G. Effects of vaginally delivered estrogens. Acta Obstet Gynecol Scand Suppl 1996; 163: 1-2.
8. Hextall A. Oestrogens and lower urinary tract function. Maturitas 2000; 36: 83-92.
9. Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower uninary tract. Am J Obstet Gynecol 1981; 141: 817-20.
10. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T. Postmenopausal hormones and incontinence: the Heart and Estrogen/ Progestin Replacement Study. Obstet Gynecol 2001; 97: 116-20.
11. Lindgren R, Berg G, Hammar M, Zuccon E. Hormonal replacement therapy and sexuality in a population of Swedish postmenopausal women. Acta Obstet Gynecol Scand 1993; 72: 292-7.
12. Gupta S, Kumar N, Singhal N, Manektala U, Jain S, Sodhani P. Cytohormonal and morphological alterations in cervicovaginal smears of post- menopausal women on hormone replacement therapy. Diagn Cytopathol 2006; 34: 676-81.
13. Hammond DO. Cytological assessment of climacteric patients. Clin Obstet Gynaecol 1977; 4: 49-70.
14. Meisels A. The maturation value. Acta Cytol 1967; 11: 249.
15. Greendale GA, Zibecchi L, Petersen L, Ouslander JG, Kahn B, Ganz PA. Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric 1999; 2: 197-204.
16. Galhardo CL, Soares JM Jr, Simoes RS, Haidar MA, Rodrigues de Lima G, Baracat EC. Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy. Clin Exp Obstet Gynecol 2006; 33: 85-9.
17. American Psychaitric Association. Diagnostic and statistical manual of mental disorders DSM-IV. 4th ed. Washington, DC: American Psychaitric Association; 2000.
18. Kaufman SA. Limited relationship of maturation index to estrogen therapy for menopausal symptoms. An analysis of 200 patients. Obstet Gynecol 1967; 30: 399-407.
19. Nilsson K, Risberg B, Heimer G. The vaginal epithelium in the postmenopause - cytology, histology and pH as methods of assessment. Maturitas 1995; 21: 51-6.
20. Davila GW, Singh A, Karapanagiotou I, Woodhouse S, Huber K, Zimberg S, et al. Are women with urogenital atrophy symptomatic? Am J Obstet Gynecol 2003; 188: 382-8.
21. Capewell AE, McIntyre MA, Elton RA. Post- menopausal atrophy in elderly women: is a vaginal smear necessary for diagnosis? Age Ageing 1992; 21: 117-20.
22. Roy S, Caillouette JC, Roy T, Faden JS. Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol 2004; 190: 1272-7.
23. Cauci S, Driussi S, De Santo D, Penacchioni P, Iannicelli T, Lanzafame P, et al. Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol 2002; 40: 2147-52.
24. Gregersen N, Jensen PT, Giraldi AE. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Dan Med Bull 2006; 53: 349-53.
25. Omu AE, al Qattan N. Effects of hormone replacement therapy on sexuality in post- menopausal women in a mideast country. J Obstet Gynaecol Res 1997; 23: 157-64.
26. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-12.
27. Vardy MD, Lindsay R, Scotti RJ, Mikhail M, Richart RM, Nieves J, et al. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 2003; 189: 81-8.
28. Rymer J, Chapman MG, Fogelman I, Wilson PO. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994; 18: 127-33.